These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 17434910)

  • 41. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic and prognostic significance of antibodies against citrullinated peptides].
    Schulze-Koops H; Manger B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
    Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
    J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does a positive anti-CCP test identify a distinct arthritis entity?
    Skogh T
    Arthritis Res Ther; 2005; 7(6):230-2. PubMed ID: 16277697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis].
    Lemos A; Ramos MP; Furtado MJ; Carvalho C; Santos MJ; Silva JC; Ventura H
    Acta Reumatol Port; 2007; 32(4):345-9. PubMed ID: 18159201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
    Madan A; Belshaw R; Grennan D
    QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
    [No Abstract]   [Full Text] [Related]  

  • 47. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.
    van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM; Mosaad YM; Youssef HM
    Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L; Uddhammar A; Rantapää-Dahlqvist S
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract]   [Full Text] [Related]  

  • 50. The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactions.
    Lee W; Weisman MH
    J Rheumatol; 2006 Jul; 33(7):1216-8. PubMed ID: 16821260
    [No Abstract]   [Full Text] [Related]  

  • 51. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies.
    Vasishta A
    Am Clin Lab; 2002; 21(7):34-6. PubMed ID: 12380030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 54. The new criteria for classification of rheumatoid arthritis: what we need to know for clinical practice.
    Corrao S; Calvo L; Licata G
    Eur J Intern Med; 2011 Jun; 22(3):217-9. PubMed ID: 21570636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies in rheumatoid arthritis: a review.
    Mewar D; Wilson AG
    Biomed Pharmacother; 2006 Dec; 60(10):648-55. PubMed ID: 17064873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 57. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
    Zendman AJ; van Venrooij WJ; Pruijn GJ
    Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946
    [No Abstract]   [Full Text] [Related]  

  • 58. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?
    Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C
    Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
    Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
    Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
    [No Abstract]   [Full Text] [Related]  

  • 60. Autoantibodies in normals--the value of predicting rheumatoid arthritis.
    Dörner T; Hansen A
    Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.